Main > ENDOCRINOLOGY > Diabetes. Treatment > SaxaGliptin (DPP-IV Inhibitor) > Co.: USA. B. Approved/Patents

---

Co.: USA. B. Approved/Patents's subsections
Company
DPP = DiPeptidyl Peptidase
JP Rights Sold To:
Partner Company
Patent>Assignee; Claims; No.: Etc.
Patent>Total USA No.: 2
Patent>UpDate: 01.30.07
Patent>US Expiration: 02.16.2021
Structural IUPAC Name
TradeMark
Web-Site

Co.: USA. B. Approved/Patents's products
This section has no products